Urgent action Needed: Antimicrobial Resistance Threatens European Healthcare,Claims Millions Globally
The Hague – A growing crisis of antimicrobial resistance (AMR) is jeopardizing health systems across Europe,including the Netherlands,and contributing to a staggering global death toll,according to a recent analysis highlighting the critical need for increased international investment in global health initiatives. The warning comes as policymakers prepare budget allocations, underscoring the urgency of prioritizing preventative measures and bolstering healthcare systems worldwide.
AMR occurs when microorganisms like bacteria, viruses, fungi and parasites no longer respond to medicines designed to kill them, making infections harder to treat and increasing the risk of disease spread and complications. This poses a direct threat to common medical procedures. Routine operations like caesarean sections and hip replacements, alongside vital treatments such as chemotherapy, are increasingly at risk of becoming ineffective. The consequences are severe, leading to more disabilities and deaths.
The World health Institution reports that AMR already contributes to approximately 5 million deaths annually worldwide, with 1.27 million directly attributable to infections from resistant bacteria. A notably devastating impact is seen in children, with an estimated 1 million under the age of five dying each year from AMR-related infections. In 2022, that number tragically rose to over 3 million children. Children are especially vulnerable due to their developing immune systems.
A key driver of AMR is excessive antibiotic use, particularly in low and middle-income countries. Limited access to quality care, preventative measures, and vaccines fuels the spread of resistant bacteria, which then travel globally through trade and travel, impacting even Europe. In 2020 alone, approximately 100 people per day died in Europe due to the consequences of AMR.
The issue transcends national borders, with no effective “border controls for diseases.” Experts emphasize the necessity of a global approach, advocating for strengthened support for initiatives like GAVI and the Global Fund. These organizations are vital in guaranteeing equitable access to vaccines, medicines, and preventative tools, while together strengthening health systems globally.
Investing in these initiatives isn’t simply an act of international solidarity,but a crucial act of self-protection,safeguarding both global populations and the health security of the Netherlands. Without concerted, collaborative action, easily treatable diseases risk becoming life-threatening onc again.
